QTTB — Q32 Bio Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1661998 ·
Last close
$7.09
Market Cap
$120.22M
52W High
$8.05
52W Low
$4.17
ADV30
310,717
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,722,000 | -7,609,000 | 63,675,000 | 50,751,000 | 17,362,000 |
| Dec 2025 | 53,737,000 | — | 45,879,000 | 57,730,000 | 61,776,000 | 48,297,000 | 19,762,000 |
| Sep 2025 | 0 | — | -7,577,000 | -7,389,000 | 57,784,000 | 49,039,000 | 76,232,000 |
| Jun 2025 | 0 | — | -9,171,000 | -9,489,000 | 66,117,000 | 54,832,000 | 78,352,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-33,543,000
Investing CF
$7,000,000
Financing CF
$-3,125,000
CapEx
$-60,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.74
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-204,993,000
Inventory
—
Receivables
$5,392,000
ST Investments
—
EBIT TTM
$30,921,000
Pretax Income TTM
$29,821,000
Interest Exp TTM
$1,100,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$53,737,000
EBITDA
$21,770,000
Free Cash Flow
$9,871,000
Enterprise Value
$61,242,208
Total Cash
$50,751,000
Total Debt
$13,646,000
Shares Out
16,956,415
Trailing EPS
$2.78
Book Value
$3.17
ROE
157.2%
ROA
18.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 53,737,000 | 16,902,000 | 29,821,000 | 61,776,000 | 19,762,000 | — | -33,543,000 |
| Dec 2024 | 0 | -66,102,000 | -47,733,000 | 92,332,000 | 86,657,000 | — | -67,715,000 |
| Dec 2023 | -6,651,000 | -48,255,000 | -53,743,000 | 47,057,000 | 229,978,000 | — | -18,677,000 |
| Dec 2022 | 6,651,000 | -39,225,000 | -42,809,000 | 61,774,000 | 192,486,000 | — | -10,957,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-5.36
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLYX | Polaryx Therapeutics, Inc. | $122.15M | $2.58 | — |
| HSTC | HST Global, Inc. | $117.39M | $0.83 | — |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $123.50M | $1.16 | — |
| INDP | Indaptus Therapeutics, Inc. | $125.70M | $1.11 | — |
| VTVT | vTv Therapeutics Inc. | $130.61M | $33.16 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet
2026-05-26 13:55 · Yahoo
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade
2026-05-08 13:55 · Yahoo
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-05 10:59 · Yahoo
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?
2026-04-30 19:10 · Yahoo
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference
2026-04-08 10:59 · Yahoo
Does Q32 Bio (QTTB) Have the Potential to Rally 97.66% as Wall Street Analysts Expect?
2026-03-30 13:55 · Yahoo
Best Momentum Stocks to Buy for March 27th
2026-03-27 14:15 · Yahoo
New Strong Buy Stocks for March 27th
2026-03-27 08:35 · Yahoo
Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know
2026-03-19 16:00 · Yahoo
Best Momentum Stocks to Buy for March 19th
2026-03-19 14:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.